Maze interim chief Charles Homcy passes baton to Jason Coloma; William Collier tapped as CEO of Arbutus
→ Four months into Maze Therapeutics’ launch, Charles Homcy is passing the startup’s reins to another Third Rock
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
